TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. - Wikidata - awgldk - TriplyDB

TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

http://www.wikidata.org/entity/Q37179756

about

TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43 Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability Neuropathology of non-Alzheimer degenerative disorders Modeling ALS and FTD with iPSC-derived neurons Parallel manifestations of neuropathologies in the enteric and central nervous systems TDP-43: a new player on the AD field?TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPT Potential mechanisms of progranulin-deficient FTLD The function of RNA-binding proteins at the synapse: implications for neurodegeneration Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease Therapeutic and diagnostic challenges for frontotemporal dementia Hyperphosphorylation as a defense mechanism to reduce TDP-43 aggregation TDP-43 aggregation in neurodegeneration: are stress granules the key?Spreading of pathology in neurodegenerative diseases: a focus on human studies Hippocampal Sclerosis of Aging Can Be Segmental: Two Cases and Review of the Literature Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging The tau tubulin kinases TTBK1/2 promote accumulation of pathological TDP-43 β-amyloid triggers ALS-associated TDP-43 pathology in AD models TARDBP 3'-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology.Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2.Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis.The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration Selective forelimb impairment in rats expressing a pathological TDP-43 25 kDa C-terminal fragment to mimic amyotrophic lateral sclerosis.Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) mice.Risk Factors and Pathological Substrates Associated with Agitation/Aggression in Alzheimer's Disease: A Preliminary Study using NACC Data Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants.Multiprotein deposits in neurodegenerative disorders: our experience in the tissue brain bank of Navarra.ALS and FTLD: two faces of TDP-43 proteinopathy.Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration.Elucidating the genetics and pathology of Perry syndrome.TDP-43 is a developmentally regulated protein essential for early embryonic development.Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases A Drosophila model for TDP-43 proteinopathy.Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease.TDP-43 regulates its mRNA levels through a negative feedback loop.

P2860

Q24594172-BD111DBD-F9EC-4DCB-83EC-748344298B2D Q24634907-1E4AD401-303F-4786-80F4-4FAA346A2E30 Q24648173-7509D750-4A9B-476B-A950-BAA98CF435BD Q24657571-FDA8C739-788B-4F57-8674-620EF97EB0D3 Q26783672-E43FF5A3-7F2E-4957-8E99-799D75D6542C Q26823182-2F41B817-A44D-4D36-8D70-69F4CF89EC2E Q26823723-A51E3E09-BBCB-4690-8DD3-A1109F114854 Q26851112-47907A28-B3A9-416A-A48A-7F7F71862ABF Q26863702-5271726C-9203-40E9-9376-FE5C1F5A2592 Q26991684-EBC0A2B7-EE2D-4938-8BC5-F531F231A3D3 Q26996741-4957FCE0-D151-404D-BA82-CEE3F30B1B6C Q26998919-FD8C1371-5CF9-4700-A6CC-F001AFC78A87 Q27325625-DA900B81-E557-49FB-82B8-BB9ABAC350F3 Q27692111-AD2F39F7-5BDB-43E5-9392-98A0C1614F08 Q28082279-28B52CC0-FA4A-4D1A-85FF-9851A326472A Q28083841-D50579AE-B41F-4DB5-B851-884C3725BEE0 Q28250864-F85C1C5F-DA49-412E-979F-022277168DE9 Q28473603-A74EA231-082D-4237-B055-1ED766A8552B Q28477836-DFB5C97A-D9CC-447A-856C-4EE7870DAED3 Q28542476-77A7CBC8-F9A4-4573-8A7F-E47E2565F9CB Q28580544-F6A98F79-61A3-484D-89F7-9D8157EDCBA0 Q28749802-61A1CA4D-798B-4CF2-88F6-4DC102DF1D68 Q29417099-0D8C352B-7C1D-49DA-92E5-47D54D6D975B Q30493972-A22B254A-BF38-45FA-9CD6-185FD7C4B88D Q30494776-15273266-A59F-4C1D-A3A6-D593C72DBD3A Q30495415-589E389C-7B50-45F2-BCA9-7557F60B63A8 Q30541190-3EECBD8E-2ED9-49EC-9713-C02FA2114743 Q30583228-5486F252-1FB0-4719-A124-EAA56DA10131 Q31146615-AC3C16C7-BF36-4327-B903-BEDD1697A3B9 Q33361835-2B72E840-668A-421A-A797-B74EF7E717AC Q33453702-370C8000-BE8B-4C4E-A501-034547E41CB7 Q33571116-F3101654-E027-4A4F-BC7E-9C1E6E915CD4 Q33601762-0E18AC97-4C52-4ED1-809B-436C14EC18A7 Q33618272-DC2D87A8-82EB-4605-9F81-82B1093F13D2 Q33673895-28972C7D-AA30-48E8-B2D0-06C3CFAAF43F Q33685317-3F65B205-E0C8-497D-9207-459F58971323 Q33692255-EA597B64-1F5E-434C-BBD4-A36A1B6CB509 Q33733651-2AA62714-E80B-41C3-90CC-32F04773D9AC Q33745617-3B1435D7-6B7D-4123-AA3D-404D733A2577 Q33763346-41094191-F63F-4C84-A9F2-4A22655C7663

P2860

TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

http://www.wikidata.org/entity/Q37179756

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

@en

TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

@nl

type

label

TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

@en

TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

@nl

prefLabel

TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

@en

TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

@nl

P1433

Q37179756-24FC1608-1249-401D-87ED-3FCB9FDEDCA6

P1476

Q37179756-53C56044-9C16-405F-BB51-BAE011573055

P2093

Q37179756-019ED654-5E02-466B-8525-1C1C641A89A0

Q37179756-1010CC3B-38EC-41FF-AA23-6A365421F16C

Q37179756-270E06CC-C63F-4EBD-B845-03BDD62A998A

Q37179756-5CF8DD61-65FE-4F70-B2AE-1EA77731A0D3

Q37179756-5DD0D0CB-A3CD-4FE0-A34F-3764638B82D0

Q37179756-9A62B2C0-886F-4B84-8F42-DC4E3E18DE49

Q37179756-C7449635-2251-48F9-BA2B-67E0877E3A8A

Q37179756-DBAEC6F0-A727-45A0-9C28-0B7899F5D318

P2860

Q37179756-00B5209E-FD34-49CA-AFFA-780914A2EC50

Q37179756-05683333-0245-4B23-A9B6-8EC1BBBBDD8A

Q37179756-0C88EF12-448D-48EE-AD79-2F4570926EB2

Q37179756-18C30362-5840-4B59-94C8-4B4D553208FA

Q37179756-1E8D4658-14C2-4DA6-8349-94BCD4ECB26E

Q37179756-212DD6E6-D588-47D3-ADCE-9AD54AAD3706

Q37179756-24E0B052-AC1D-4821-B2BE-6F53587DE504

Q37179756-2E08ADC1-5B9A-486F-93FF-A832C937C9A0

Q37179756-2FAB2B51-9DFF-42D1-9002-94CD17E3B4BD

Q37179756-3C5B306D-E60B-43AB-915F-EEEA23E13154

P304

Q37179756-82545C66-D6B3-4A15-8480-53857D428CD6

P31

Q37179756-251A42FB-E8F8-4A6B-BBA1-EADD857A9327

P356

Q37179756-751BE261-BAC0-4050-BCE4-7CC7473C1CC7

P433

Q37179756-E94FB0FB-10D0-48F3-8734-25B45BE045B7

P478

Q37179756-6B28FC8B-634A-4CCA-9685-57E73C1F22CB

P50

Q37179756-E6E0A049-00AE-475D-A444-5D0D5C1B289F

P577

Q37179756-C0C294CE-6CF0-4E4B-845A-26FF42DE8C89

P5875

Q37179756-6BB46C6B-B7A2-4038-85A4-2036FC626323

P698

Q37179756-F72F95DF-F727-49E8-8FE5-BF7AD45E412D

P921

Q37179756-2BC1DCE0-1853-4FCC-AF46-EBF24287CE31

P932

Q37179756-835A769F-DB24-4872-A207-1AF8A6DA9D56

P356

P1433

Annals of Neurology

P1476

TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

@en

P2093

Catalina Amador-Ortiz

http://www.w3.org/2001/XMLSchema#string

David Personett

http://www.w3.org/2001/XMLSchema#string

Michael L Hutton

http://www.w3.org/2001/XMLSchema#string

Neill R Graff-Radford

http://www.w3.org/2001/XMLSchema#string

Peter Davies

http://www.w3.org/2001/XMLSchema#string

Ranjan Duara

http://www.w3.org/2001/XMLSchema#string

Wen-Lang Lin

http://www.w3.org/2001/XMLSchema#string

Zeshan Ahmed

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer Disease in the US Population

Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Tau suppression in a neurodegenerative mouse model improves memory function

Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred.

New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis.

Argyrophilic grain disease: neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E.

Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank.

P304

435-445

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.21154

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P50

Dennis W. Dickson

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6361098

http://www.w3.org/2001/XMLSchema#string

P698

17469117

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2677204

http://www.w3.org/2001/XMLSchema#string